Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2015 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (241)	1/15/2015 12:32:56 PM
From: Arthur Radley	Respond to of 407

forbes.com I was beginning to think this guy was becoming an 'over promoter' of himself, and so it appears that one of his employees thinks the same thing.

To: scaram(o)uche who wrote (241)	1/15/2015 3:36:29 PM
From: Steve Lokness	Read Replies (1) \| Respond to of 407

<<<<< Anyway, structured to mimic that purchase, to foster scientific independence? >>>>> Oh geez! On first blush after the first Roche purchase of shares - how did shareholders of Genentech do? That was a long time ago. I don't know the cultures in either compnay to understand what the Foundation agreement ultimately means. I guess one result will be that Foundation will not need to spend management time on niggling management issues such as stock price or take-out snooping. ............So then to add a bit of intrigue; Switzerland makes the announcement on the change in their currency policy this morning!